Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2004

View Archived Issues

PSK-3471: a novel SERM prevents bone loss and restores bone mass in rodents/News in Context

Seliciclib induces apoptosis in multiple myeloma cell lines

Alfimeprase shows efficacy in the treatment of occluded CVADs

Aerosolized Radilex superior to muscle injection following radiation exposure

AVI BioPharma updates NeuGene antisense program progress

Helicon launches phase I studies of IPL-455903

PLX-647 selected for development for inflammatory diseases

Recordati to develop silodosin for BPH in Europe

Equetro approved for bipolar disorder

HuMax-CD20 IND accepted for phase I/II study in RA

ExonHit synthesizes small molecule in Allergan collaboration

FoldRx completes Series A financing

ViRexx and AltaRex shareholders vote in favor of acquisition

KetoCytonyx completes phase I study of KTX-0101

R-207910: a novel diarylquinolone for the treatment of tuberculosis

TASQ enters clinical studies in prostate cancer patients

ZymoGenetics updates pipeline progress

Pfizer issues Bextra safety warnings

Commercial launch for Evoclin

Financing at NeoTropiX

Natural product boosts proteoglycan synthesis in chondrocytes via upregulation of TGF-beta2

PPARalpha and gamma agonists for prevention and treatment of atherosclerosis

GCS-100 induces apoptosis through different pathways in MM and B-cell lymphoma/leukemia cells

Update on the antitumor effects of forodesine in hematological malignancies

Antibacterial pleuromutilin derivatives claimed by GlaxoSmithKline

New dopamine D3 receptor ligands in early development at Abbott

A series of analgesic agents prepared and tested by Boehringer Ingelheim

Novel MMP-3 inhibitors described in patent literature

Scientists at Maruha report Edg receptor antagonists

A series of spiropiperidine derivatives presented by Merck & Co.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...